Based on publicly available RNA-seq data from the Cancer Genome Atlas (TCFA), DLBCL is another B-cell malignancy that expresses LCK at significantly higher levels compared with matched normal cells (Fig. 5A). Here, LCK is linked to diffuse large B-cell lymphoma.